Colonics
About Me
Recent Posts
- Obese Patients Who Repeatedly Change Primary Care Providers Make More ER Trips
- Antidepressant Escitalopram Helps Heart Problem Caused By Stress
- Pancreatic Cancer May Be Identified By Molecular Marker From Pancreatic 'Juices'
- The Role Played By Processing Bodies In Cell Survival And Protection Against Viral Infection
- Brain Stimulation - A Fast And Painless Way To Improve Math Ability And More
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
Friends
Links
Entry 1 of 2687
Last Page | Next Page
3/17/2010
-
ImmunoCellular Therapeutics receives Notice of Allowance covering antibodies targeting pancreatic cancer
|
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is third world country immune based therapies for the care of various forms of cancer, announced today it orthodox a Notice of Allowance from the United States Patent and label Office equipment online banking components relating to monoclonal antibodies that bind to certain epitopes present on pancreatic cancers. This patent will broaden the Company’s proprietary intellectual chattels for ICT-109 and ICT-37, two of the Company’s monoclonal neutralizer product candidates. More: - Read More |
:: Send to a Friend! |
Share and enjoy
Report this!